» Articles » PMID: 10759686

Relative Contribution of Cytochromes P-450 and Flavin-containing Monoxygenases to the Metabolism of Albendazole by Human Liver Microsomes

Overview
Specialty Pharmacology
Date 2000 Apr 12
PMID 10759686
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Albendazole (ABZ; methyl 5-propylthio-1H-benzimidazol-2-yl carbamate) is a broad spectrum anthelmintic whose activity resides both in the parent compound and its sulphoxide metabolite (ABS). There are numerous reports of ABZ metabolism in animals but relatively few in humans. We have investigated the sulphoxidation of ABZ in human liver microsomes and recombinant systems.

Methods: The specific enzymes involved in the sulphoxidation of ABZ were determined by a combination of approaches; inhibition with an antiserum directed against cytochrome P450 reductase, the effect of selective chemical inhibitors on ABZ sulphoxidation in human liver microsomes, the capability of expressed CYP and FMO to mediate the formation of ABS, regression analysis of the rate of metabolism of ABZ to ABS in human liver microsomes against selective P450 substrates and regression analysis of the rate of ABS sulphoxidation against CYP expression measured by Western blotting.

Results: Comparison of Vmax values obtained following heat inactivation (3min at 45 degrees C) of flavin monoxygenases (FMO), chemical inhibition of FMO with methimazole and addition of an antiserum directed against cytochrome P450 reductase indicate that FMO and CYP contribute approximately 30% and 70%, respectively, to ABS production in vitro. Comparison of CLint values suggests CYP is a major contributor in vivo. A significant reduction in ABZ sulphoxidation (n = 3) was seen with ketoconazole (CYP3 A4; 32-37%), ritonavir (CYP3 A4: 34-42%), methimazole (FMO: 28-49%) and thioacetamide (FMO; 32-35%). Additive inhibition with ketoconazole and methimazole was 69 +/- 8% (n = 3). ABS production in heat - treated microsomes (3 min at 45 degrees C) correlated significantly with testosterone 6beta-hydroxylation (CYP3A4; P < 0.05) and band intensities on Western blots probed with an antibody selective for 3A4 (P < 0.05). Recombinant human CYP3 A4, CYP1A2 and FMO3 produced ABS in greater quantities than control microsomes, with those expressing CYP3A4 producing threefold more ABS than those expressing CYP1A2. Kinetic studies showed the Km values obtained with both CYP3A4 and FMO3 were similar.

Conclusions: We conclude that the production of ABS in human liver is mediated via both FMO and CYP, principally CYP3A4, with the CYP component being the major contributor.

Citing Articles

Combining solubilization and controlled release strategies to prepare pH-sensitive solid dispersion loaded with albendazole: and studies.

Su D, Bai M, Wei C, Long X, Liu X, Shen X Front Vet Sci. 2025; 11:1522856.

PMID: 39758610 PMC: 11695277. DOI: 10.3389/fvets.2024.1522856.


Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole.

Cole S, Malamatari M, Butler A, Arshad M, Kerwash E CPT Pharmacometrics Syst Pharmacol. 2024; 13(11):1990-2001.

PMID: 39558864 PMC: 11578140. DOI: 10.1002/psp4.13260.


Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats.

Li C, Zhang Y, Pang M, Zhang Y, Hu C, Fan H Antimicrob Agents Chemother. 2024; 68(5):e0144923.

PMID: 38501660 PMC: 11064478. DOI: 10.1128/aac.01449-23.


HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature.

Liao J, Zhan Y, Zhang Z, Cui J, Yin J Front Pharmacol. 2023; 14:1288068.

PMID: 38027017 PMC: 10670799. DOI: 10.3389/fphar.2023.1288068.


Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis.

Hernandez-Ceron M, Chavarria V, Rios C, Pineda B, Palomares-Alonso F, Rojas-Tome I Brain Sci. 2023; 13(6).

PMID: 37371349 PMC: 10295958. DOI: 10.3390/brainsci13060869.


References
1.
McManus M, Stupans I, Burgess W, Koenig J, Hall P, Birkett D . Flavin-containing monooxygenase activity in human liver microsomes. Drug Metab Dispos. 1987; 15(2):256-61. View

2.
Halpert J, Guengerich F, Bend J, Correia M . Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol. 1994; 125(2):163-75. DOI: 10.1006/taap.1994.1061. View

3.
Horton R . Benzimidazoles in a wormy world. Parasitol Today. 1990; 6(4):106. DOI: 10.1016/0169-4758(90)90225-s. View

4.
Omura T, Sato R . THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964; 239:2370-8. View

5.
Fargetton X, Benoit E, Totis M, Batt A . Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics. Toxicol Appl Pharmacol. 1988; 92(1):141-9. DOI: 10.1016/0041-008x(88)90236-0. View